EUCTR2004-003195-11-DE进行中（未招募）不适用
The effect of the co-administration of multiple oral doses of the fructose-1,6-bisphosphatase (FBPase) inhibitor CS-917 and glibenclamide on pharmacokinetics, safety and tolerability in diabetic patients (NIDDM) - Not available
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Male or female subjects with non-insulin dependent type 2 diabetes mellitus (NIDDM) documented by C-peptide secretion (C-peptide =0.2 pmol/mL) at screening
- •2. Diet-treated subjects or subjects in whom it is medically justifiable to withdraw oral anti-diabetic treatment during the study
- •3. Negative serum pregnancy test at screening and check-in of each period. Females of childbearing potential should either be sexually inactive (abstinent) for 14 days prior to the first dose and throughout the study or should use one of the following acceptable birth control methods: (1) barrier methods, including condoms (males), and diaphragms (cervical caps) with intra-vaginal spermicide (including jellies, foams and suppositories), or (2) intra-uterine device (IUD) for the entire duration of their participation in the study and up to one month (i.e. one complete menstrual cycle) whichever is longer, after the last dose of study drug.
- •Note: A female of non-childbearing potential will be defined as one who has been post-menopausal for at least one year or has been surgically sterilised or had a hysterectomy at least three months prior to screening.
- •4. 18–70 years of age (inclusive)
- •5. BMI 22–35 kg/m2
- •6. HbA1c of =6.5% at screening
- •7. Fasting plasma glucose (FPG):
- •at screening: =16.7 mmol/L (=300 mg/dL) and
- •on Day –1 prior to first dosing: 8.9–16.7 mmol/L (160–300 mg/dL), inclusive
- •8. Normotensive subjects or stable blood pressure on anti-hypertensive medication
- •9. Signed Informed Consent Form
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Subjects with type 1 diabetes or need for insulin (IDDM)
- •2. Subjects with diabetic complications
- •3. Subjects who experienced hypoglycaemic episodes in the past 6 months
- •4. Need for concomitant medication; use of prescription drugs within 14 days or use of non-prescription drugs within seven days (including herbals) with the following exception: stable treatment with anti-hypertensive (beta-blockers are not allowed), antilipidaemic or antirheumatic agents, and medication for coronary heart disease
- •5. Intake of any investigational drug within three months prior to the first intake of study medication (Day 1 of Period 1).
- •6. Severe drug allergy or serum sickness
- •7. Serum creatinine >110 µmol/L for female and >135 µmol/L for male subjects at screening
- •8. Abnormalities of liver function parameters or any abnormal result in haematology or clinical chemistry results
研究者
相似试验
招募中
1 期
Study of Pharmacokinetics of BMS-708163 in Healthy SubjectsCTRI/2009/091/000914Bristol-Myers Squibb Research and Development311 Pennington-Rocky Hill RoadPennington, NJ 0853416
招募中
2 期
Comparison of the effect of simultaneous administration of oxytocin with Foley catheter with co-administration of misoprostol and Foley catheter on cervical preparation and duration of laborextended pregnancies.Obstructed labor, unspecifiedO66.9IRCT20181123041731N2Mashhad University of Medical Sciences74
进行中（未招募）
不适用
Study of Mometasone Furoate Nasal Spray and Oxymetazoline Nasal Spray Given Together Once A Day To Treat Seasonal Allergic Rhinitis (P04500)EUCTR2014-004924-23-Outside-EU/EEASchering-Plough Research Institute, a Division of Schering Corporation875
招募中
不适用
Investigation of the synergistic effects of Multiple Drilling and Magneto-therapy on Knee Osteochondritis Dissecan.Knee Osteochondritis Dissecan.Osteochondritis dissecansM93.2IRCT20200819048462N1Ahvaz University of Medical Sciences36
进行中（未招募）
不适用
Effects of the administrartion of two different dosages of eparin on activation of coagulation pathway and of fibrinolisis and on platenet function in patients with myocardial revascolarization open heart - NDEUCTR2007-001443-22-ITAZIENDA OSPEDALIERA OSPEDALE POLICLINICO CONSORZIALE